New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of its enhanced SureSeq CLL + CNV ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

A precise and realistic TPP can define a clear path to market and commercial success by bridging the gap between research and ...

Curve Therapeutics has appointed Rab Prinjha as Chief Research and Development (R&D) Officer. Rab is a proven R&D leader with ...

How industry and the NHS can work together to bridge the diagnostic gap in COPD Lord Darzi’s recent report on the state of ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...

Revised additional risk minimisation guidelines – change for the better ...

Our luminaries look across the pharmaverse with conclusions and curiosity ...

How the UK medical cannabis market is tackling supply chain strain ...

Imagine cruising down a highway, with the hum of the engine and road beneath you, travelling towards your destination. On the ...